The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Randomized Clinical Trial of Metronidazole Plus Erythromycin to Prevent Spontaneous Preterm Delivery in Fetal Fibronectin–Positive Women
Abstract
OBJECTIVE: To estimate whether antibiotic treatment of asymptomatic women with a positive cervical or vaginal fetal fibronectin test in the second trimester would reduce the risk of spontaneous preterm delivery. METHODS: Women were screened between 21 weeks 0 days and 25 weeks 6 days of gestation with cervical or vaginal swabs for fetal fibronectin. Women with a positive test (50 ng/mL or more) were randomized to receive metronidazole (250 mg orally three times per day) and erythromycin (250 mg orally four times per day) or identical placebo pills for 10 days. The primary outcome was spontaneous delivery before 37 weeks' gestation after preterm labor or premature membrane rupture. RESULTS: A total of 16,317 women were screened for fetal fibronectin, and 6.6% had a positive test; 715 fetal fibronectin test-positive women consented to randomization. Outcome data were available for 703 women: 347 in the antibiotic group and 356 in the placebo group. The antibiotic and placebo groups were not significantly different for maternal age (P =.051), ethnicity (P =.849), marital status (P =.127), education (P =.244), and bacterial vaginosis (P =.236). No difference was observed in spontaneous preterm birth before 37 weeks' (odds ratio [OR] 1.17, 95% confidence interval [CI] 0.80, 1.70), less than 35 weeks' (OR 0.92, 95% CI 0.54, 1.56), or less than 32 weeks' (OR 1.94, 95% CI 0.83, 4.52) gestation in antibiotic- compared with placebo-treated women. Among women with a prior spontaneous preterm delivery, the rate of repeat spontaneous preterm delivery at less than 37 weeks' gestation was significantly higher in the active drug compared with the placebo group (46.7% versus 23.9%, P =.039). CONCLUSION: Treatment with metronidazole plus erythromycin of asymptomatic women with a positive cervical or vaginal fetal fibronectin test in the late second trimester does not decrease the incidence of spontaneous preterm delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intrauterine infection and preterm delivery
Goldenberg, R. L., Hauth, J. C., & Andrews, W. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422007 · Cited by 2,548
Self-citationDiscrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Properties of the urn randomization in clinical trials
Wei, L. J., & Lachin, J. M. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90048-7 · Cited by 308
The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth
GOLDENBERG, R., MERCER, B., MEIS, P., COPPER, R., DAS, A., & MCNELLIS, D. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(96)00035-x · Cited by 281
Self-citation
Cited by
Iams, J. D., Romero, R., Culhane, J. F., & Goldenberg, R. L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60108-7 · Cited by 500
Self-citationLeitich, H., & Kiss, H. (2007) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2006.12.005 · Cited by 342
Prevention of Preterm Delivery
Simhan, H. N., & Caritis, S. N. (2007) · New England Journal of Medicine · doi:10.1056/nejmra050435 · Cited by 292
Self-citationAdjunctive Azithromycin Prophylaxis for Cesarean Delivery
Tita, A. T. N., Szychowski, J. M., Boggess, K., Saade, G., Longo, S., Clark, E., Esplin, S., Cleary, K., Wapner, R., Letson, K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602044 · Cited by 287
Self-citationBiochemical markers for the prediction of preterm birth
Goldenberg, R. L., Goepfert, A. R., & Ramsey, P. S. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.02.015 · Cited by 187
Metadata
- Authors
- Andrews, W. W., Sibai, B. M., Thom, E. A., Dudley, D., Ernest, J. M., McNellis, D., Leveno, K. J., Wapner, R., Moawad, A., OʼSullivan, M. J., Caritis, S. N., Iams, J. D., Langer, O., Miodovnik, M., & Dombrowski, M.
- Venue
- Obstetrics & Gynecology
- Published
- 2003-05
- Volume
- 101
- Issue
- 5, Part 1
- Pages
- 847-855
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2135511588
- Cited by
- 197
- References
- 4
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized Clinical Trial of Metronidazole Plus Erythromycin to Prevent Spontaneous Preterm Delivery in Fetal Fibronectin–Positive Women. https://app.cochat.ai/papers/10.1016/s0029-7844(03)00172-8
- The paper
- Andrews, W. W., Sibai, B. M., Thom, E. A., Dudley, D., Ernest, J. M., McNellis, D., Leveno, K. J., Wapner, R., Moawad, A., OʼSullivan, M. J., Caritis, S. N., Iams, J. D., Langer, O., Miodovnik, M., & Dombrowski, M. (2003). Randomized Clinical Trial of Metronidazole Plus Erythromycin to Prevent Spontaneous Preterm Delivery in Fetal Fibronectin–Positive Women. Obstetrics & Gynecology. https://doi.org/10.1016/s0029-7844(03)00172-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.